DKNG
DraftKings Inc.
DKNG has a slight edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
DKNG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Stable |
DKNG's revenue, cash flow and balance sheet are currently stable, but its profitability is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DKNG PE Valuation
DKNG has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
DKNG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect DKNG's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DKNG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.77 | -$0.23 |
| Q2 2026 | -$0.35 | +$0.27 |
| Q1 2026 | $0.09 | +$0.91 |
| Q4 2025 | -$0.01 | +$1.04 |
| Q3 2025 | -$0.54 | +$0.34 |
| Q2 2025 | -$0.62 | +$0.27 |
| Q1 2025 | -$0.82 | +$0.34 |
| Q4 2024 | -$1.05 | +$0.68 |
DKNG has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
DKNG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +16% |
| Q2 2026 | $1.4B | -4.6% |
| Q1 2026 | $1.6B | +17% |
| Q4 2025 | $2B | +43% |
| Q3 2025 | $1.1B | +4.4% |
| Q2 2025 | $1.5B | +37% |
| Q1 2025 | $1.4B | +20% |
| Q4 2024 | $1.4B | +13% |
DKNG's revenue is growing: $1.3B last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -37% | -13 points |
| Q2 2026 | -4.7% | -15 points |
| Q1 2026 | 0.4% | +3.6 points |
| Q4 2025 | 7.6% | +18 points |
| Q3 2025 | -24% | +3.5 points |
| Q2 2025 | 10% | +13 points |
| Q1 2025 | -3.3% | +8.5 points |
| Q4 2024 | -10% | -6.4 points |
DKNG has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over DKNG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
DKNG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$43.7M | -115% |
| Q2 2026 | $106.9M | -37% |
| Q1 2026 | -$55.5M | +$66.1M |
| Q4 2025 | $316.5M | -2.1% |
| Q3 2025 | $283M | +116% |
| Q2 2025 | $169.6M | +529% |
| Q1 2025 | -$121.7M | -$48.2M |
| Q4 2024 | $323.2M | +355% |
DKNG has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
DKNG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +843K shares |
| 1 year | +0.1% | +293K shares |
| 3 years | +6.9% | +32.2M shares |
| 5 years | +23% | +93.1M shares |
| Available history | +170% | +313M shares |
DKNG has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $55.6M |
| Q1 2026 | $98.6M |
| Q4 2025 | $257.6M |
| Q3 2025 | $71.2M |
| Q2 2025 | $100.5M |
| Q1 2025 | $142.3M |
| Q4 2024 | $30.1M |
DKNG spent $412M buying back its own shares over the past year, up 20% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
DKNG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.5x | Moderate |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.5x | Very low |
DKNG's net debt is about 2.5 years of its operating earnings (EBITDA).
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DKNG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 25.3 | Neutral |
DKNG's weekly RSI is 39 (neutral) and its Stochastic is 25 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DKNG PE vs Consumer Cyclical Sector
| Metric | DKNG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
DKNG has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
DKNG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.8 | 3.5% below |
| 20 week MA | $22.7 | 16% below |
| 50 week MA | $25.3 | 24% below |
| 100 week MA | $32.1 | 40% below |
| 200 week MA | $32.5 | 41% below |
DKNG is in a downtrend: it's below all five of its weekly moving averages, and 41% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
DKNG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.7 | $52.1 | +388% |
| 2021 | $52.1 | $29.4 | -44% |
| 2022 | $29.4 | $11.5 | -61% |
| 2023 | $11.5 | $35.3 | +206% |
| 2024 | $35.3 | $37.9 | +7.6% |
| 2025 | $37.9 | $34.9 | -8% |
| 2026 YTD | $34.9 | $19.1 | -45% |
DKNG has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.